Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Mirati Therapeutics, Inc. | 151,171 | reported | 20 Jan 2023 | tx 8+516,827−7,795 |
| Cullinan Therapeutics, Inc. | 38,513 | reported | 12 Jun 2025 | tx 2+54,131 |
| uniQure N.V. | 34,190 | reported | 20 Jun 2025 | tx 25+135,046−8,849 |
| ENDOCYTE INC | 7,500 | reported | 06 Feb 2014 | tx 7+302,500−10,000 |
| Entasis Therapeutics Holdings Inc. | 0 | reported | 11 Jul 2022 | tx 13+100,307−100,307 |
| Fusion Pharmaceuticals Inc. | 0 | reported | 04 Jun 2024 | tx 2+34,000−34,000 |
| Baxalta Inc | 0 | reported | 03 Jun 2016 | tx 13+348,507−348,822 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Jun 2025 | SALE | uniQure N.V. | 2,112 | 14.45 USD | |
| 12 Jun 2025 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 38,513 | 0.00 USD | deriv |
| 11 Jun 2025 | GRANT_AWARD | uniQure N.V. | 7,970 | 0.00 USD | |
| 11 Jun 2025 | GRANT_AWARD | uniQure N.V. | 15,630 | 0.00 USD | deriv |
| 19 Jun 2024 | GRANT_AWARD | uniQure N.V. | 8,080 | 0.00 USD | |
| 19 Jun 2024 | GRANT_AWARD | uniQure N.V. | 15,840 | 0.00 USD | deriv |
| 13 Jun 2024 | SALE | uniQure N.V. | 2,229 | 5.12 USD | |
| 04 Jun 2024 | OTHER | Fusion Pharmaceuticals Inc. | 34,000 | — | deriv |
| 15 May 2024 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 15,618 | 0.00 USD | deriv |
| 16 Oct 2023 | GRANT_AWARD | Fusion Pharmaceuticals Inc. | 34,000 | 0.00 USD | deriv |
| 13 Jun 2023 | GRANT_AWARD | uniQure N.V. | 8,700 | 0.00 USD | |
| 16 Jun 2023 | SALE | uniQure N.V. | 2,290 | 18.85 USD | |
| 13 Jun 2023 | GRANT_AWARD | uniQure N.V. | 17,060 | 0.00 USD | deriv |
| 27 Feb 2023 | SALE | uniQure N.V. | 389 | 19.71 USD | |
| 20 Jan 2023 | GRANT_AWARD | Mirati Therapeutics, Inc. | 89,379 | 0.00 USD | |
| 20 Jan 2023 | GRANT_AWARD | Mirati Therapeutics, Inc. | 151,233 | 0.00 USD | deriv |
| 17 Jan 2023 | SALE | Mirati Therapeutics, Inc. | 3,179 | 42.38 USD | |
| 19 Dec 2022 | GRANT_AWARD | Mirati Therapeutics, Inc. | 35,425 | 0.00 USD | |
| 21 Dec 2022 | SALE | Mirati Therapeutics, Inc. | 4,616 | 40.41 USD | |
| 07 Jul 2022 | TENDER | Entasis Therapeutics Holdings Inc. | 22,000 | 2.20 USD | |
| 11 Jul 2022 | OTHER | Entasis Therapeutics Holdings Inc. | 27,500 | 2.20 USD | |
| 11 Jul 2022 | OTHER | Entasis Therapeutics Holdings Inc. | 17,307 | 0.00 USD | deriv |
| 11 Jul 2022 | OTHER | Entasis Therapeutics Holdings Inc. | 11,000 | 0.00 USD | deriv |
| 15 Jun 2022 | GRANT_AWARD | uniQure N.V. | 9,080 | 0.00 USD | |
| 15 Jun 2022 | GRANT_AWARD | uniQure N.V. | 17,810 | 0.00 USD | deriv |